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Researchers designing pragmatic, multi-centre randomised
controlled trials (RCTs) in critical care are faced with
numerous potential methodological challenges. These
challenges can be outlined using PICO terminology:
Population
Unlike many other clinical areas, patients admitted to
intensive care units (ICUs) do not have easily identifi-
able diseases (e.g. diabetes or cancer), but are classified
as having syndromes with hazy definitions that may be
inconsistently applied both within and between centres.
The definition and implementation of inclusion and
exclusion criteria is therefore difficult, resulting in clini-
cally heterogeneous populations.
Intervention and control
Due to the rapidly declining condition of patients in
ICU “treatment as usual” consists of many therapies
that can vary both within and between centres. Often,
control and experimental care are complex interventions
with minimal differences between treatment protocols
and there is a risk of treatment contamination due to
creep from control to intervention treatment, particu-
larly when blinding is not feasible. Protocolising control
group treatment is essential but non-compliance may be
frequent.
Outcome
The gold standard outcome in critical care research is
all-cause mortality reduction. However, ICU patients
often have multiple life threatening conditions and
RCTs require large sample sizes due to small anticipated
effect sizes of interventions on mortality. Alternative
outcomes used are composite or combined outcomes.
Composite outcomes may be difficult to interpret and
combined outcomes, e.g. ventilator free days, pose analy-
sis challenges.
We will discuss the trade-offs between pros and cons
of potential solutions to the problems outlined above.
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